FY 2025
Loading financial data...
|
Chart |
FY21
Dec 31, 2021
|
FY22
Dec 31, 2022
|
FY23
Dec 31, 2023
|
FY24
Dec 31, 2024
|
FY25
Dec 31, 2025
|
TTM
Trailing 12M
|
|---|---|---|---|---|---|---|---|
|
Revenue
Total sales generated. |
|
$17.74 B | $18.88 B | $6.85 B | $3.20 B | $1.94 B | $2.23 B |
|
Cost of Revenue Direct cost of goods/services. |
|
$2.62 B | $5.42 B | $4.69 B | $1.46 B | $868.00 M | $2.53 B |
Gross Profit Revenue minus cost of revenue. |
|
$15.12 B | $13.46 B | $2.16 B | $1.74 B | $1.08 B | -$309.00 M |
|
Operating Expense
Costs to run business. 
|
|
$1.82 B | $4.04 B | $6.39 B | $5.68 B | $4.15 B | $3.10 B |
Operating Income Profit from operations. |
|
$13.30 B | $9.42 B | -$4.24 B | -$3.95 B | -$3.07 B | -$3.41 B |
|
Net Interest Income
Interest income minus expense.
|
|
- | $171.00 M | $383.00 M | $401.00 M | - | $278.00 M |
Non-Operating Income (ex-Int) Income outside core operations. |
|
- | - | -$335.00 M | -$362.00 M | - | -$221.00 M |
Total Other Income (Net) Net non-operating items. |
|
-$11.00 M | $155.00 M | $297.00 M | $338.00 M | $306.00 M | $274.00 M |
Income Before Tax Profit before taxes. |
|
$13.29 B | $9.58 B | -$3.94 B | -$3.61 B | -$2.77 B | -$3.14 B |
Income Tax Expense Taxes on income. |
|
$1.08 B | $1.21 B | $772.00 M | -$46.00 M | $54.00 M | $56.00 M |
|
Net Income
Final profit.
|
|
$12.20 B | $8.36 B | -$4.71 B | -$3.56 B | -$2.82 B | -$3.19 B |
|
Earnings Per Share
Company profit allocated to each outstanding share. |
|||||||
EPS Earnings per share. Formula: Net Income ÷ Shares |
|
$30.31 | $21.26 | -$12.34 | -$9.27 | -$7.26 | -$8.15 |
Diluted EPS EPS including dilution. Formula: Net Income ÷ Diluted Shares |
|
$28.29 | $20.10 | -$12.34 | -$9.27 | -$7.26 | -$8.15 |
|
Shares for EPS
Number of shares used to calculate EPS. |
|||||||
Weighted Average Shares Outst. Avg shares used for EPS. |
|
403.00 M | 394.00 M | 382.00 M | 384.00 M | 389.00 M | 395.00 M |
Diluted Average Shares Outst. Shares including dilution. |
|
431.00 M | 416.00 M | 382.00 M | 384.00 M | 389.00 M | 395.00 M |
| Supplemental Items | |||||||
EBIT Earnings before interest and tax. |
|
$13.30 B | $9.42 B | -$3.90 B | -$3.58 B | - | -$3.19 B |
EBITDA Earnings before interest, tax, D&A. |
|
$13.53 B | $9.77 B | -$3.28 B | -$3.39 B | -$3.07 B | -$2.96 B |
Depreciation and Amortization Non-cash expense for assets. |
|
$232.00 M | $348.00 M | $621.00 M | $189.00 M | - | $235.00 M |
| Company Report |
FY 2025
Moderna's Balance Sheet
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading balance sheet when needed... |
Moderna's Cash flow
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading cash flow statement when needed... |
Moderna's Profitability
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
| Loading profitability metrics when needed... |
Moderna's Ratios
-
$ USD
-
€ EUR
-
€ EUR
-
€ EUR
-
-
-
